Aytu Biopharma (AYTU) Return on Invested Capital (2015 - 2026)

Aytu Biopharma (AYTU) has 7 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.

• On a quarterly basis, Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.01%, down from 0.0% in the prior quarter.
• Over the last five years, Return on Invested Capital for AYTU reached as high as 0.0% in Q2 2023 and fell as low as 0.05% in Q2 2022.
• Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
• Across the five-year window, Return on Invested Capital slipped 2 bps in 2022 and climbed 6 bps in 2023, its largest moves.
• Year by year, Return on Invested Capital stood at 0.04% in 2022, then soared by 73 bps to 0.01% in 2023, then climbed by 14 bps to 0.01% in 2024, then jumped by 53 bps to 0.0% in 2025, then plunged by 46 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.